Clarification

doi:10.1093/jnci/92.3.190

Article Navigation

Journal Article

Extract

In a Jan. 5, 2000, News article (p.6) on STI-571, a new drug that selectively targets chronic myelogenous leukemia cells, it was stated that Herceptin® (trastuzumab) was the first monoclonal antibody to be approved by the Food and Drug Administration for cancer treatment. However, the first was actually Rituxan® (rituximab), which was approved and marketed in November 1997 for the treatment of non-Hodgkins B-cell lymphoma.

You do not currently have access to this article.

Download all slides

Sign in with email/username & password
Get email alerts
Save searches
Purchase content
Activate your purchase/trial code
Add your ORCID iD

Get help with access

Institutional access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institutionâ€™s website and Oxford Academic.

Click Sign in through your institution.
Select your institution from the list provided, which will take you to your institution's website to sign in.
When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institutionâ€™s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see â€˜Sign in through society siteâ€™ in the sign in pane within a journal:

Click Sign in through society site.
When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
Following successful sign in, you will be returned to Oxford Academic.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

Personal account

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

View your signed in personal account and access account management features.
View the institutional accounts that are providing access.

Signed in but can't access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

Institutional account management

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Purchase

Subscription prices and ordering for this journal

Purchasing options for books and journals across Oxford Academic

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Clarification - 24 Hours access

EUR €39.00

GBP £33.00

USD $43.00

Rental

This article is also available for rental through DeepDyve.

Views

496

Altmetric

Total Views 496

496 Pageviews

0 PDF Downloads

Since 11/1/2017

Month:	Total Views:
November 2017	2
December 2017	4
January 2018	2
February 2018	2
March 2018	3
April 2018	3
May 2018	2
June 2018	1
July 2018	2
August 2018	2
December 2018	2
January 2019	2
February 2019	24
March 2019	36
April 2019	6
May 2019	4
June 2019	4
July 2019	1
September 2019	2
October 2019	17
November 2019	28
December 2019	58
January 2020	66
February 2020	10
March 2020	9
April 2020	1
May 2020	3
July 2020	3
September 2020	3
November 2020	1
February 2021	4
March 2021	3
April 2021	1
May 2021	1
June 2021	17
July 2021	2
August 2021	18
September 2021	18
October 2021	13
November 2021	7
January 2022	1
February 2022	10
March 2022	1
April 2022	6
May 2022	2
June 2022	7
July 2022	6
August 2022	6
September 2022	2
October 2022	2
November 2022	2
December 2022	1
January 2023	1
February 2023	1
March 2023	1
July 2023	1
August 2023	5
September 2023	1
October 2023	1
November 2023	2
December 2023	2
January 2024	1
April 2024	1
May 2024	1
June 2024	2
July 2024	1
August 2024	3
September 2024	7
October 2024	8
November 2024	4
December 2024	2
January 2025	5
February 2025	4
March 2025	8
April 2025	1

Clarification

Extract

Citations

Views

Altmetric

Email alerts

Citing articles via

Latest

Most Read

Most Cited

Looking for your next opportunity?

Clarification

Extract

Sign in

Personal account

Institutional access

Institutional account management

Get help with access

Institutional access

IP based access

Sign in through your institution

Sign in with a library card

Society Members

Sign in through society site

Sign in using a personal account

Personal account

Viewing your signed in accounts

Signed in but can't access content

Institutional account management

Purchase

Short-term Access

Rental

Citations

Views

Altmetric

Email alerts

Citing articles via

Latest

Most Read

Most Cited

Looking for your next opportunity?

This Feature Is Available To Subscribers Only